Prellis: Prellis Biologics snaps up $14.5m Series B
Prellis Biologics, which is launching a vitro human antibody discovery platform, has secured $14.5 million in Series B financing.
Read full article »
Prellis is a California-based biotechnology firm that develops and supplies 3D printed lymph nodes drug discovery and development systems for the healthcare industry.
Read more